FortunePatients First: Transforming Care Through Disruptive TechnologyMay 26, 2022Media CoverageRelated contentTempus Announces 13 Abstracts Accepted for Presentation at the European Society for Medical Oncology Congress 2026Tempus Receives FDA Clearance for its ECG-MR AI Product Designed to Identify Undiagnosed Mitral RegurgitationTempus and Recursion Extend Existing Data License Agreement and Enter New License Agreement for Recursion’s RNA Foundation Model